Chan W. Lee, Chief Operations Officer of Ambarella Inc, filed a Form 4 on September 18, 2026, disclosing the sale of 2,893 ordinary shares on September 17, 2026, to cover tax obligations arising from the vesting of restricted stock units.
Chi-Hong Ju, Senior Vice President of Systems and General Manager at Ambarella Inc (NASDAQ:AMBA), filed a Form 4 on September 18, 2026, reporting the sale of 2,009 ordinary shares on September 17, 2026, to cover tax obligations from vesting restricted stock units.
Feng-Ming Wang, CEO and Director of Ambarella Inc, filed a Form 4 on September 18, 2026, disclosing the sale of 6,086 ordinary shares on September 17, 2026, to cover tax obligations arising from the vesting of restricted stock units.
Wupen Yuen, President of Global Business Units at Lumentum Holdings Inc. (NASDAQ:LITE), filed a Form 4 on September 18, 2026, disclosing the sale of 1,500 shares of common stock across three consecutive trading days under a pre-established Rule 10b5-1 trading plan.
A statement of changes in beneficial ownership was filed on September 18, 2026, disclosing that Thomas M. Ryan, a director at PJT Partners Inc. (NYSE:PJT), acquired 19 restricted stock units representing dividend equivalent rights accrued on existing RSU holdings.
Lee Ji-Yeun, a Managing Partner at PJT Partners Inc., filed a statement of changes in beneficial ownership on September 18, 2026, disclosing the acquisition of restricted stock units as dividend equivalent rights on September 16, 2026.
Helen T. Meates, Chief Financial Officer of PJT Partners Inc., filed a statement of changes in beneficial ownership on September 18, 2026, reporting the acquisition of 21 restricted stock units on September 16, 2026.
Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc. (NASDAQ:HQY), filed a Form 4 on September 18, 2026, reporting a gift transaction in the company's common stock dated September 17, 2026.
Bruno Sousa Mauad, a director of Aura Minerals Inc. (NASDAQ:AUGO), filed a Form 4 with the SEC disclosing multiple transactions in common shares and Brazilian Depositary Receipts on September 17, 2026, all held indirectly through Kapitalo Investimentos.
Director Melvina Wong-Zaza filed a Form 4 with the SEC on September 18, 2026, disclosing an open-market purchase of Kearny Financial Corp. common stock on September 17, 2026.